GHB in Sydney, Australia, 2000-2006: A case study of the EDRS as a strategic early warning system

International Journal of Drug Policy

Volumn 20, Issue 5, 2009, Pages 413-417

  Dunn, Matthew ^a   Topp, Libby ^b,c   Degenhardt, Louisa ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Justice Health Centre for Health Research in Criminal Justice   (Australia)

Author keywords

Drug related harm; GHB; Illicit drug use; Sentinel surveillance

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID;

ARTICLE; AUSTRALIA; CASE STUDY; DRUG CONTROL; DRUG MISUSE; DRUG TRAFFIC; INFORMATION PROCESSING; LAW ENFORCEMENT; MANDATORY REPORTING; PRIORITY JOURNAL; TREND STUDY;

DRUG AND NARCOTIC CONTROL; EXPERT TESTIMONY; HUMANS; NEW SOUTH WALES; POPULATION SURVEILLANCE; PREVALENCE; SODIUM OXYBATE; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 67651244493     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2009.01.002     Document Type: Article

References (44)

1. Addolorato G., Caputo F., Capristo E., Setafanini G.F., and Gasbarrini G. Gamma-hydroxybutyric acid: efficacy, potential abuse, and dependence in the treatment of alcohol addiction. Alcohol 20 (2000) 217-222
2. Australian Institute of Health and Welfare. 2004 National Drug Strategy Household Survey: First results (2005), Australian Institute of Health and Welfare, Canberra
3. Australian Institute of Health and Welfare. 2007 National Drug Strategy Household Survey: First results (2008), Australian Institute of Health and Welfare, Canberra
4. Biernacki P., and Waldorf D. Snowball sampling: Problems, techniques and chain referral sampling. Sociological Methods for Research 10 (1981) 141-163
5. Caldicott D., Chow F., Burns B., Felgate P., and Byard R.W. Fatalities associated with the use of gamma-hydroxybutyrate and its analogues in Australiasia. Medical Journal of Australia 181 (2004) 310-313
6. Chin M., Kreutzer R., and Dyer J. Acute poisoning from gamma-hydroxybutyrate overdose. Annals of Emergency Medicine 31 (1992) 716-722
7. Darke S., Kaye S., and Topp L. Cocaine use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS). Drug and Alcohol Dependence 67 (2002) 73-79
8. Degenhardt L. Patterns of drug use and risk behaviours among regular ecstasy users: Does sexuality make a difference?. CultureHealth and Sexuality (2005)
9. Degenhardt L., Agaliotis M., White B., and Stafford J. NSW Trends in Ecstasy and Related Drug Markets 2004: Findings from the Party Drugs Initiative (PDI) (2005), National Drug and Alcohol Research Centre, University of New South Wales, Sydney
10. Degenhardt L., Copeland J., and Dillion P. Recent trends in the use of "club drugs": An Australian review. Substance Use & Misuse 40 (2005) 1241-1256
11. Degenhardt L., Darke S., and Dillon P. GHB use among Australians: Characteristics, use patterns, and associated harm. Drug and Alcohol Dependence 67 (2002) 89-94
12. Degenhardt L., Darke S., and Dillon P. The prevalence and correlates of GHB overdose among Australian users. Addiction 98 (2003) 199-204
13. Degenhardt L., and Dunn M. The epidemiology of GHB and ketamine use in an Australian household survey. International Journal of Drug Policy 19 (2008) 311-316
14. Dunn M., and Degenhardt L. NSW trends in ecstasy and related drug markets 2006: Findings from the Ecstasy and Related Drugs Reporting System (EDRS) (2007), National Drug and Alcohol Research Centre, University of New South Wales, Sydney
15. Dunn M., Degenhardt L., and Stafford J. NSW trends in ecstasy and related drug markets 2005: Findings from the Party Drugs Initiative (PDI) (2006), National Drug and Alcohol Research Centre, University of New South Wales, Sydney
16. Friedman J., Westlake R., and Furman M. Grievous bodily harm": Gamma hydroxybutyrate abuse leading to the Wernicke-Korsakoff syndrome. Neurology 46 (1996) 469-471
17. Gallimberti L., Canton G., Gentile N., Ferri M., Cibin M., Ferrara S.D., et al. Gamma-hydroxybutyric acid for treatment of alcohol withdrawl syndrome. Lancet 2 (1989) 787-789
18. Gallimberti L., Cibin M., and Pagnin P. Gamma hydroxybutyric acid for the treatment of opiate withdrawal syndrome. Neuropsychopharmacology 9 (1993) 77-81
19. Galloway G., Frederick S., Staggers F., Gonzales M., Stalcup S., and Smith D. Gamma-hydroxybutyrate: An emerging drug of abuse that causes physical dependency. Addiction 92 (1997) 89-96
20. Gonzalez A., and Nutt D.J. Gamma hydroxy butyrate abuse and dependence. Journal of Psychopharmacology 19 (2005) 195-204
21. Hando J., Darke S., O'brien S., Maher L., and Hall W. The development of an early warning system to detect trends in illicit drug use in Australia: The Illicit Drug Reporting System. Addiction Research 6 (1998) 97-113
22. Hando J., Topp L., and Hall W. Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. Drug and Alcohol Dependence 46 (1997) 105-113
23. Kelleher A. The unobtrusive researcher: A guide to methods (1993), Allen & Unwin, Sydney
24. Kerlinger F.N. Foundations of behavioral research (1986), CBS Publishing Limited, Japan
25. Kinner S., and Degenhardt L. Reflections on the development and implementation of an early warning system for ecstasy and related drug markets in Australia. Drug and Alcohol Review 25 (2006) 445-449
26. Maxwell J.C. The response to club drug use. Current Opinion in Psychiatry 16 (2003) 279-289
27. McCambridge J., Mitcheson L., Winstock A., and Hunt N. Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom. Addiction 100 (2005) 1140-1149
28. Miotto K., Darakjian J., Basch J., Murray S., Zogg J., and Rawson R. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. American Journal on Addictions 10 (2001) 232-241
29. Nicholson K., and Balster R. GHB: A new and novel drug of abuse. Drug and Alcohol Dependence 63 (2001) 1-22
30. SPSS Inc. SPSS for Windows version 14.0. 14.0 ed. (2005), SPSS Inc., Chicago
31. Substance Abuse and Mental Health Services Administration Office of Applied Studies. Drug Abuse Warning Network, 2005 (2007), National Estimates of Drug-Related Emergency Department Visits, Rockville, MD
32. Topp L., Barker B., and Degenhardt L. The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug and Alcohol Dependence 73 (2004) 33-40
33. Topp L., Breen C., Kaye S., and Darke S. NSW Party Drug Trends 2001: Findings from the Illicit Drug Reporting System (IDRS) Party Drugs Module (2002), National Drug and Alcohol Research Centre, University of New South Wales, Sydney
34. Topp L., Breen C., Kaye S., and Darke S. Adapting the Illicit Drug Reporting System (IDRS) methodology to examine the feasibility of monitoring trends in party drug markets. Drug and Alcohol Dependence 73 (2004) 189-197
35. Topp L., and Darke S. NSW Party Drug Trends 2000: Findings of the Illicit Drug Reporting System Party Drugs Module (2001), National Drug and Alcohol Research Centre, University of New South Wales, Sydney
36. Topp L., Hando J., Dillon P., Roche A., and Solowij N. Ecstasy use in Australia: Patterns of use and associated harm. Drug & Alcohol Dependence (1999) 55
37. Topp, L., Hall, W., & Hando, J. (1997). Is there a dependence syndrome for ecstasy? NDARC Technical Report No. 51. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
38. Topp L., and McKetin R. Supporting evidence-based policy-making: A case study of the Illicit Drug Reporting System. Bulletin on Narcotics (2003) 23-30 LV (vols. 1 and 2)
39. Vickers M. Gammahydroxybutyric acid. Proceedings of the Royal Society of Medicine 61 (1968) 821-823
40. White, B., Breen, C., & Degenhardt, L. (2003). New South Wales Party Drugs Trends 2002: Findings from the Illicit Drug Reporting System (IDRS) Party Drugs Module. NDARC Technical Report Number 162. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
41. White B., Breen C., and Degenhardt L. New South Wales Party Drug Trends 2003: Findings from the Party Drugs Initiative (2004), National Drug and Alcohol Research Centre, University of NSW, Sydney
42. Whitten L. Conference highlights increasing GHB abuse. NIDA Notes 16 (2001) 10-11
43. Wu L.T., Schlenger W., and Galvin D. Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB and flunitrazepam among American youths. Drug and Alcohol Dependence 84 (2006) 102-113
44. Zablotska I., Prestage G., Hull P., Crawford J., Kippax S., Sutherland R., et al. Sydney Gay Community Periodic Survey February 1996 to February 2006 (2006), National Centre in HIV Social Research and National Centre in HIV Epidemiology and Clinical Research, Sydney